Scientists at the Institute for Problems of Chemical and Energetic Technologies (IPCET) and collaborators have developed tiovyurtsin, a generic drug for the treatment of pain. The new analgesic lacks the side effects typical of steroid and non-steroidal anti-inflammatory drugs.
"As a raw material for the new drug, we used glyoxal—a substance for which the industrial technology of synthesis was developed by chemists at Tomsk State University," said Sergey Sysolyatin, the director of the IPCET SB RAS (a graduate of TSU's Faculty of Chemistry). "High-energy compounds are also based on glyoxal. At the intermediate stage of synthesis, we are withdrawing a small portion of the substance, modifying it, and then obtaining a drug with excellent pharmacological characteristics."
Preclinical tests carried out at the ED Goldberg Research Institute of Pharmacology and Regenerative Medicine (Tomsk) showed that the new analgesic suppresses pain symptoms of various etiologies and has a longer period of effectiveness than other painkillers, with no toxic effects on the body.
This appears to be an update on research reported in January 2016 in Medical Express: New drug could be safer, non-addictive alternative to morphine, which references an abstract appearing in the journal: Neuropharmacology DOI: 10.1016/j.neuropharm.2015.12.024
(Score: 1, Touché) by Anonymous Coward on Tuesday October 18 2016, @07:58AM
No wonder the comments are sparse and crap
I see what you did there. . .